Trasylol Lawyers at Anapol Schwartz | Philadelphia Pennsylvania Attorneys at Law
  Do I have a Trasylol case? ... Contact us for a free consultation with one of our Trasylol Lawyers

About Trasylol

Heart Attack Risk after Heart Surgery

Bayer Suspends Trasylol Sales November 5, 2007

Benefits of Retaining Anapol Schwartz

Do you have a Trasylol case?

pdf guide

FDA Gets Trasylol Off the Market

BART Study Enrollment Ceases due to problems with Trasylol Safety.

Trasylol Wrongful Death Complaint

Do you have a NSF lawsuit?

Web Resources

Blog

 

Kidney Dialysis Risk

Contact us for a free legal consultation about your Trasylol Lawsuit


Clotting Drug Trasylol/aprontin Increases Kidney Dialysis Risk

In January 2006 an independent study with no-ties to big pharmaceutical funding proved that Trasylol/aprontin had doubled a patient’s risk to kidney dialysis and increased the risk of heart attack, heart failure, and stroke.

Bayer AG’s aprotin has been on the worldwide market since 1993 and given to an estimated one million patients. As the demand for heart bypass surgery grows so does the need for kidney dialysis. What has become almost a routine cardiac surgery is now much more dangerous when patients receive aprontin to curb blood loss. Do you have an unsafe drug aprotin lawsuit?

These results were based on an independent, observational study conducted by the Ischemia Research and Education Foundation (IREF), in association with the McSPI Research Group, both nonprofit biomedical research organizations, dedicated to saving and extending lives.

According to the study replacing Aprotin with one of two safe generic drugs would annually prevent as many as 11,000 kidney dialysis complications; save at least $1 billion in healthcare (dialysis) costs; and reduce drug costs by at least $250 million.

Figures show that each year approximately one million patients worldwide undergo surgical treatment following a heart attack, with the majority of these patients receiving one of three antifibrinolytic agents to limit blood loss during surgery, Aprotin produced by Bayer Healthcare, or one of the generic drugs aminocaproic acid and tranexamic acid.

The two generic drugs have proven safe in limiting blood loss and do not have the harmful effects of Aprotin. Patients scheduled for cardiac surgery are advised to consult their physician and avoid this risk. Unfortunately, most patients are not that savvy and simply trust the decision of their doctors and hospitals.

Have you or a loved one found it necessary to receive kidney dialysis after open heart bypass surgery or have you suffered a heart attack or stroke from receiving the injection Aprontin during heart bypass surgery? Do you need an aprontin lawyer?

Do you have a Trasylol/Aprotinin Lawsuit?

Do you need a Trasylol/aprotinin lawyer to fight for you? Do you have an unsafe aprotinin lawsuit? Isn’t it about time to consider the options?

PERSONAL INFORMATION



First Name:
Last Name:
E-mail Address:
Phone: () - ext.
Address:
City:
State:
Zipcode:
Date of birth of injured person:


TRASYLOL LAWSUIT INFORMATION

Date of surgery:
Have you (or injured party) experienced any of the following? (check all that apply)
Kidney failure
Stroke
Heart attack
Heart failure
Encephalopathy/brain disease
Death
Did you (or injured party) require dialysis? Yes No
Please describe the side effects you experienced:
Other information:

Copyright © 2004- - Anapol Schwartz - Pennsylvania Trasylol Lawyers Our Attorneys in Pennsylvania and New Jersey Trasylol Lawyers - Trasylol Class Action Law Firm. All rights reserved.

Trasylol Attorney Disclaimer:This website is dedicated to providing public information regarding Trasylol and other legal information. None of the information on this site is intended to be formal legal advice, nor the formation of a lawyer or attorney client relationship. Please contact a Pennsylvania Trasylol lawyer in Philadelphia - Ask a Trasylol attorney at our law firm for information regarding your particular case. This website is not intended to solicit clients outside the States of New Jersey, Pennsylvania, and West Virginia.